January 2017 | Vol. 2, Issue 2 IBM

Expanding Data Choices for Research

This is a sub-headline.

Make The Switch

To the clinical knowledge solution that more hospitals are using.
Ready to see what Micromedex can do for your organization? Complete the form below to be contacted by a Truven Health representitve.

Primary landing page headline goes right here

Subhead copy here should be no more than 4-line max. Subhead copy here should be no more than 4-line max. Subhead copy here should be no more than 4-line max.

CTA Headline!

Lorum ipsum dolore acit.kirium. Lorum ipsum dolore acit denate kirium. Lorum ipsum dolore acit denate kirium.

What physicians in the European Union Five countries take into account when considering switching to biosimilars for treating psoriasis and psoriatic arthritis patients currently on Remicade, Enbrel or Humira

We conducted a survey of prescribing clinicians in each of the European Union Five countries to better understand their prescribing habits around biosimilars. This research brief reports on the findings.

Please complete this form to request the survey results.

Header goes here!
Lorem ipsum dolor sit amet, discere probatus cum ea, cu lorem error eam, no solet numquam mea. Usu eu amet phaedrum iudicabit, sea ea hinc fugit reprehendunt. Ius idque iudico eu. Ut tritani fastidii scribentur duo, eos et nihil doming audiam, aperiam scripserit ut mea. Homero salutatus ne quo. Id usu volutpat efficiendi philosophia, his id senserit reprimique. At qui animal ancillae intellegat. Mea illum audiam corpora et, movet utinam ad mea. Case omnesque mei ea, te justo laudem docendi pri. Cu ius deleniti voluptaria, nec diam appellantur referrentur id.
Lorem ipsum dolor sit amet, mi tincidunt, velit libero posuere vel eleifend congue, ullamcorper pretium. Lectus ut auctor, suspendisse curabitur tempus ac, suspendisse interdum leo tempor. Aenean phasellus velit conubia donec sit praesent. Gravida aenean vehicula cras sit accumsan, condimentum et parturient nec adipiscing ac, lobortis pulvinar. Dui sapien velit porttitor fusce diam neque, a vestibulum mollis donec, neque phasellus, viverra porta leo pellentesque, eros tristique. Interdum vel mi ipsum, sodales porttitor eget vitae aliquet sit, pellentesque culpa, porta venenatis vestibulum, odio dolor ut imperdiet. Laoreet libero pharetra, sodales nulla, blandit morbi integer pulvinar nonummy pellentesque consectetuer. Augue wisi dapibus felis leo malesuada, ut elementum in vivamus proin, lorem torquent tellus velit massa elit, id suspendisse aenean luctus, in ac ut et turpis. Eleifend dolor eu lectus phasellus, vitae vehicula curabitur id scelerisque sagittis tincidunt. Porta sed aenean mus lacus, enim vitae. Nisl tortor adipiscing in in, ad phasellus habitasse lobortis nec wisi mi, velit mauris gravida morbi, vulputate risus in justo voluptates. In ipsum libero id, purus ut gravida ante dis condimentum aut, mauris cursus.

New Drug Treatment Pattern Capability!

Faster, easier, and more informative.

New Drug Treatment Pattern Capability!

Faster, easier, and more informative.

Feature A

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature B

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature C

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature A

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature B

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature C

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature A

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature B

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature A

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.

Feature B

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint.
A verified business, nonprofit, government, or academic email address is required for fulfillment. We reserve the right not to fulfill requests from competitors and those containing an unverified email address, and apologize for any inconvenience.